First long-acting hair regrowth pill hailed as 'new benchmark'
2 days ago
- #hair-loss-treatment
- #FDA-approval
- #minoxidil
- A new oral drug, VDPHL01, may become the first prescription pill specifically designed to regrow hair in both women and men.
- VDPHL01 is an extended-release version of oral minoxidil, originally a blood pressure medication known for promoting hair growth as a side effect.
- Unlike current oral minoxidil, VDPHL01 provides sustained release, minimizing cardiovascular risks and avoiding the mess of topical treatments like Rogaine.
- Phase 3 trials are underway in the US, with potential FDA approval sought early next year if results remain promising.
- In a Phase 2 study, participants saw significant hair growth (37.5 hairs/cm² after two months, 47.3 after four) and high satisfaction rates (91% visible improvement, 95% satisfaction).
- No serious or cardiac side effects have been reported, making it well-tolerated so far.
- Dr. Jerry Shapiro, a dermatology professor and advisor, believes VDPHL01 could set a new benchmark for treating pattern hair loss.
- Pattern hair loss affects ~80 million Americans, but treatment options are limited. VDPHL01 could be the first new therapy in decades for both genders.